HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lin Z Li Selected Research

Triple Negative Breast Neoplasms

1/2022Optical Redox Imaging Is Responsive to TGFβ Receptor Signalling in Triple-Negative Breast Cancer Cells.
5/2021Optical Redox Imaging of Treatment Responses to Nampt Inhibition and Combination Therapy in Triple-Negative Breast Cancer Cells.
1/2021Potential Biomarker for Triple-Negative Breast Cancer Invasiveness by Optical Redox Imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lin Z Li Research Topics

Disease

27Neoplasms (Cancer)
04/2024 - 11/2008
14Breast Neoplasms (Breast Cancer)
11/2022 - 10/2009
8Melanoma (Melanoma, Malignant)
04/2024 - 01/2009
3Triple Negative Breast Neoplasms
01/2022 - 01/2021
2Neoplasm Metastasis (Metastasis)
01/2022 - 04/2009
2Starvation
05/2021 - 01/2016
2Hemorrhagic Shock
02/2014 - 01/2014
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2013 - 01/2011
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2013 - 11/2008
1Hypoxia (Hypoxemia)
04/2024
1Alzheimer Disease (Alzheimer's Disease)
08/2022
1COVID-19
09/2020
1Carcinoma (Carcinomatosis)
12/2019
1Herpes Zoster
12/2019
1Pneumonia (Pneumonitis)
02/2016
1Carcinogenesis
03/2014
1Colonic Neoplasms (Colon Cancer)
07/2013
1Hyperoxia
01/2013
1Brain Neoplasms (Brain Tumor)
01/2013
1Glioma (Gliomas)
10/2009
1Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2008

Drug/Important Bio-Agent (IBA)

25NAD (NADH)IBA
04/2024 - 01/2009
18Biomarkers (Surrogate Marker)IBA
04/2024 - 04/2009
8FlavoproteinsIBA
04/2024 - 04/2009
5Flavin-Adenine Dinucleotide (FAD)IBA
04/2024 - 07/2013
3Lactic Acid (Lactate)FDA LinkGeneric
01/2021 - 02/2014
2Oxygen (Dioxygen)IBA
04/2024 - 01/2013
2OzoneIBA
05/2021 - 09/2020
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2020 - 01/2011
2Small Interfering RNA (siRNA)IBA
01/2019 - 05/2011
2Glucose (Dextrose)FDA LinkGeneric
03/2014 - 12/2013
2Indicators and Reagents (Reagents)IBA
02/2014 - 06/2013
1IceIBA
05/2021
1paraform (paraformaldehyde)IBA
01/2020
1cadherin 5IBA
12/2019
1Proteins (Proteins, Gene)FDA Link
12/2019
1lonidamineIBA
01/2019
1Bleomycin (Blenoxane)FDA LinkGeneric
02/2016
1Pyruvic Acid (Pyruvate)IBA
01/2016
1Glutamine (L-Glutamine)FDA Link
01/2016
1Protons (Proton)IBA
10/2014
1Therapeutic UsesIBA
03/2014
1Fixatives (Pickling Agents)IBA
06/2013
1deoxyhemoglobinIBA
01/2013
1Hematoxylin (Haematoxylon)IBA
08/2011
1Eosine Yellowish-(YS) (Eosin)IBA
08/2011
1Caspase 8 (Caspase-8)IBA
08/2011
1Death Domain ReceptorsIBA
08/2011
1Sorafenib (BAY 43-9006)FDA Link
05/2011
1Temozolomide (Temodar)FDA LinkGeneric
05/2011
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
05/2011
1NitrogenIBA
10/2009
1NucleotidesIBA
04/2009
1pyridineIBA
04/2009
1DAPIIBA
01/2009
1bryostatin 1IBA
11/2008
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2008
1Vincristine (Oncovin)FDA LinkGeneric
11/2008
1salicylhydroxamic acid (SHAM)IBA
11/2008
1Prednisone (Sone)FDA LinkGeneric
11/2008

Therapy/Procedure

3Therapeutics
05/2021 - 11/2008
3Drug Therapy (Chemotherapy)
01/2013 - 11/2008
2Photochemotherapy (Photodynamic Therapy)
11/2022 - 10/2009
1Combination Drug Therapy (Combination Chemotherapy)
11/2008